Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 2, 2003, Pages 187-190

  Chuansumrit, Ampaiwan ^a   Suwannuraks, Monthon ^a   Sri Udomporn, Nantana ^a   Pongtanakul, Bunchoo ^a   Worapongpaiboon, Surapon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Dental procedure; Glanzmann thrombasthenia; Recombinant activated factor VII

Indexed keywords

FIBRIN GLUE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STAINLESS STEEL; TRANEXAMIC ACID;

ARTICLE; BLEEDING; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ENDODONTICS; GLANZMANN DISEASE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SPLINT; TOOTH CROWN; TOOTH DISEASE; TOOTH EXTRACTION;

ADULT; BLOOD LOSS, SURGICAL; BLOOD PLATELETS; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR VII; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; MALE; ORAL HEMORRHAGE; PLATELET AGGREGATION; RECOMBINANT PROTEINS; THROMBASTHENIA; TOOTH EXTRACTION; TREATMENT OUTCOME;

EID: 0037298416     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200302000-00011     Document Type: Article

References (16)

1. Jootar S, Angchaisuksiri P, Chiewsilp P, Sathapatayavongs B, Chuncharunee S, Tanprasert S. HIV infection after autologous bone marrow transplantation despite HIV-antibody and HIV-antigen screening. Bone Marrow Transpl 1993; 12:167-168.
2. Chuansumrit A, Varavithya W, Isarangkura P, Sirinavin S, Chiewsilp P, Tanprasert S, Hathirat P. Transfusion-transmitted AIDS with blood negative for anti-HIV and HIV antigen. Vox Sang 1996; 71:64-65.
3. Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis sucessfully treated with recombinant factor VIIa. Thromb Haemost 1996; 76:981-982.
4. d'Oiron R, Menart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, et al. Use of recombinant factor VIIa in 3 patient with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures. Thromb Haemost 2000; 83:644-647.
5. Chuansumrit A, Sangkapreecha C, Hathirat P. Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa [Letter]. Thromb Haemost 1999; 82:1778.
6. Chuansumrit A, Martinowitz U, Wangruangsathit S, Kositchaiwat C, Suwannuraks M, Attanawanich S, et al. Stability of fibrin glues in body fluids. Rama Med J 2000; 23:1-8.
7. Gongsakdi C. Dental care in patients with bleeding tendency using celluloid splint. Southeast Asian J Trop Med Public Health 1979; 10:298-300.
8. Brozovic M, Stirling Y, Harricks C, North WR, Meade TW. Factor VII in an industrial population. Br J Haematol 1974; 28:381-391.
9. Suwannuraks M, Chuansumrit A, Sriudomporn N. The use of fibrin glue as an operative sealant in dental extraction in bleeding disorder patients. Haemophilia 1999; 6:106-108.
10. Poon MC, Demers C, Jobin F, Wu JWY. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94:3951-3953.
11. Poon MC, d'Oiron R, Hann I, Negrier C, de Lumley L, Thomas A, et al. Use of recombinant factor VIIa (Novo Seven) in patients with Glanzmann thrombasthenia. Semin Hematol 2001; 38(4 suppl 12):21-25.
12. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270:14477-14484.
13. Galan AM, Reverter JC, Pino M Vinas M, Lozano M, Ordinas A, et al. Increased local procoagulant action: a mechanism contributing to the favourable hemostatic effect of activated recombinant factor VIIa (rFVIIa) in quanti and qualitative disorders of platelet function [Abstract]. Thromb Haemost 2001; 86:1156.
14. Pipan CM, Glasheen WP, Matthew TI, Gonias SL, Hwang LJ, Jane JA, Spotnitz WD. Effects of antifibrinolytic agents on the life span of fibrin sealant. J Surg Res 1992; 53:402-407.
15. Sindet-Pedersen S, Ramstrom G, Bernvil S, Blomback M. Hemostatic effect of tranexamic mouthwash in anticoagulant-treated patients undergoing oral surgery. N Engl J Med 1989; 320:840-843.
16. Erhardtsen E. Pharmacokinetics of recombinant activated factor VII (rFVIIa). Semin Thromb Hemost 2000; 26:385-391.